Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A SALOMAO

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Immunotherapy|September 7, 2018
Novel immunotherapy strategies for hepatobiliary cancersThomas T DeLeon, Yumei Zhou, Bolni M Nagalo, et al.
Journal of Gastrointestinal Oncology|January 4, 2019
Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experienceThomas T DeLeon, Marcela A Salomao, Bashar A Aqel, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 13, 2025
The Histologic Spectrum of Rituximab-Associated Common Variable Immunodeficiency-Like EnteropathyPari Jafari, David Hakimian, Maria Westerhoff, et al.
Annals of Diagnostic Pathology|May 11, 2024
High risk features in colorectal adenomatous polyps: A multi-institutional studyMichael Lee, Huaibin Mabel Ko, Satoru Kudose, et al.
Cancer Chemotherapy and Pharmacology|May 23, 2020
Evaluation of NUC-1031: a first-in-class ProTide in biliary tract cancerMansi Arora, James M Bogenberger, Amro Abdelrahman, et al.
Virchows Archiv : an International Journal of Pathology|January 4, 2021
Interobserver agreement and the impact of mentorship on the diagnosis of inflammatory bowel disease-associated dysplasia among subspecialist gastrointestinal pathologistsLindsay Alpert, Namrata Setia, Huaibin Mabel Ko, et al.
IJTLD Open|July 5, 2024
Evaluation of a short training course of chest X-ray interpretation for the diagnosis of paediatric TBB F Melingui, E Leroy-Terquem, M Palmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2022
Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal JunctionMojun Zhu, Chunhua Chen, Nathan R Foster, et al.
Digestive Diseases and Sciences|November 13, 2021
FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic AlterationsPedro Luiz Serrano Uson Junior, Thomas T DeLeon, James M Bogenberger, et al.
Hepatology (Baltimore, Md.)|August 18, 2021
Synergistic combination of cytotoxic chemotherapy and cyclin-dependent kinase 4/6 inhibitors in biliary tract cancersMansi Arora, James M Bogenberger, Amro M Abdelrahman, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Immunotherapy|September 7, 2018
Novel immunotherapy strategies for hepatobiliary cancersThomas T DeLeon, Yumei Zhou, Bolni M Nagalo, et al.
Journal of Gastrointestinal Oncology|January 4, 2019
Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experienceThomas T DeLeon, Marcela A Salomao, Bashar A Aqel, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 13, 2025
The Histologic Spectrum of Rituximab-Associated Common Variable Immunodeficiency-Like EnteropathyPari Jafari, David Hakimian, Maria Westerhoff, et al.
Annals of Diagnostic Pathology|May 11, 2024
High risk features in colorectal adenomatous polyps: A multi-institutional studyMichael Lee, Huaibin Mabel Ko, Satoru Kudose, et al.
Cancer Chemotherapy and Pharmacology|May 23, 2020
Evaluation of NUC-1031: a first-in-class ProTide in biliary tract cancerMansi Arora, James M Bogenberger, Amro Abdelrahman, et al.
Virchows Archiv : an International Journal of Pathology|January 4, 2021
Interobserver agreement and the impact of mentorship on the diagnosis of inflammatory bowel disease-associated dysplasia among subspecialist gastrointestinal pathologistsLindsay Alpert, Namrata Setia, Huaibin Mabel Ko, et al.
IJTLD Open|July 5, 2024
Evaluation of a short training course of chest X-ray interpretation for the diagnosis of paediatric TBB F Melingui, E Leroy-Terquem, M Palmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2022
Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal JunctionMojun Zhu, Chunhua Chen, Nathan R Foster, et al.
Digestive Diseases and Sciences|November 13, 2021
FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic AlterationsPedro Luiz Serrano Uson Junior, Thomas T DeLeon, James M Bogenberger, et al.
Hepatology (Baltimore, Md.)|August 18, 2021
Synergistic combination of cytotoxic chemotherapy and cyclin-dependent kinase 4/6 inhibitors in biliary tract cancersMansi Arora, James M Bogenberger, Amro M Abdelrahman, et al.
Pageof 4